Roivant Sciences (Roivant Sciences) Price-to-Tangible-Book : 1.49 (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Roivant Sciences Price-to-Tangible-Book?

As of today (2024-05-27), Roivant Sciences's share price is $10.98. Roivant Sciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $7.38. Hence, Roivant Sciences's Price to Tangible Book Ratio of today is 1.49.

The historical rank and industry rank for Roivant Sciences's Price-to-Tangible-Book or its related term are showing as below:

ROIV' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.49 Med: 3.74 Max: 11.58
Current: 1.49

During the past 3 years, Roivant Sciences's highest Price to Tangible Book Ratio was 11.58. The lowest was 1.49. And the median was 3.74.

ROIV's Price-to-Tangible-Book is ranked better than
74.53% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ROIV: 1.49

A closely related ratio is called PB Ratio. As of today, Roivant Sciences's share price is $10.98. Roivant Sciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was $7.57. Hence, Roivant Sciences's P/B Ratio of today is 1.45.

Roivant Sciences Price-to-Tangible-Book Historical Data

The historical data trend for Roivant Sciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Price-to-Tangible-Book Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Price-to-Tangible-Book

2.07

5.54

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial										7.17	5.54	10.10	11.58	1.52

Competitive Comparison of Roivant Sciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Roivant Sciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roivant Sciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's Price-to-Tangible-Book falls into.

Roivant Sciences Price-to-Tangible-Book Calculation

Roivant Sciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	10.98	/	7.379
	=	1.49

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Roivant Sciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences (Roivant Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (NAS:ROIV) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

87S:Germany

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.

Executives

Eric Venker	officer: President & COO	C/O ROIVANT SCIENCES, INC., 320 WEST 37TH STREET, 6TH FLOOR, NEW YORK NY 10018
Keith S Manchester	director	C/O ROIVANT SCIENCES LTD., 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL, LONDON X0 SW1Y 4L
Daniel Allen Gold	director	6720 VIA AUSTI PARKWAY, SUITE 450, LAS VEGAS NV 89119
Qvt Financial Lp	10 percent owner, other: Director by Deputization	888 SEVENTH AVENUE, 43RD FLOOR, NEW YORK NY 10106
Svf Investments (uk) Ltd	10 percent owner	69 GROSVENOR STREET, LONDON X0 W1K3JP
Rakhi Kumar	officer: Chief Accounting Officer	C/O NEUROPACE INC, 455 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Viking Global Investors Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Performance Llc	10 percent owner	55 RAILROAD AVENUE, 3RD FLOOR, GREENWICH CT 06830
Sumitomo Chemical Co., Ltd.	10 percent owner	7-1, NIHONBASHI 2-CHOME, CHUO-KU, TOKYO M0 103-6020
Viking Global Opportunities Parent Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Softbank Vision Fund L.p.	10 percent owner	AZTEC GROUP HOUSE, 11-15 SEATON PLACE, ST HELIER Y9 JE4 0QH
Meghan Fitzgerald	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Richard Pulik	officer: CFO	SUITE 1, 3RD FLOOR, 11-12 ST. JAMES'S SQUARE, LONDON X0 SW1Y 4LB
Vivek Ramaswamy	director	C/O ONCORE BIOPHARMA, INC., 3805 OLD EASTON ROAD, DOYLESTOWN PA 18902
Dexcel Pharma Technologies Ltd.	10 percent owner	1 DEXCEL STREET, OR AKIVA L3 3060000